WILL (When to Induce Labour to Limit risk in pregnancy hypertension): a multicentre randomised controlled trial — adaptations to deliver a timing-of-birth trial during the COVID-19 international pandemic

BACKGROUND: As a pragmatic randomised timing-of-birth trial, WILL adapted its trial procedures in response to the COVID-19 pandemic. These are reviewed here to inform post-pandemic trial methodology. METHODS: The trial (internal pilot) paused in March 2020, re-opened in July 2020, and is currently r...

Descripción completa

Detalles Bibliográficos
Autores principales: Magee, Laura A., Tohill, Sue, Kirkham, Katie, Evans, Ruth, Gkini, Eleni, Moakes, Catherine A., Stubbs, Clive, Thornton, Jim, von Dadelszen, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585855/
https://www.ncbi.nlm.nih.gov/pubmed/36271441
http://dx.doi.org/10.1186/s13063-022-06834-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585855/
https://www.ncbi.nlm.nih.gov/pubmed/36271441
http://dx.doi.org/10.1186/s13063-022-06834-4

Ejemplares similares